MetaCap

Electra Therapeutics Statistics

NASDAQ: ETRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

8.11-0.83 (-9.28%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Electra Therapeutics by the numbers

Electra Therapeutics has a market capitalization of $509.8 million based on 62.87M shares outstanding. With trailing EPS of $-35.94, Electra Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.1% below its 50-day average and 14.1% below its 200-day average.

Average daily trading volume is 559.28K shares, or about $4.5 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ETRA valuation vs. peer median

ETRA compared with the median of 8 peer companies
MetricETRAPeer medianDifference
Market cap$509.85M$487.20M+5%
Avg. volume559.28K702.67K-20%

Peer median across 8 companies: VALN, DNA, SANA, RGNX, FENC, DBVT, ENTX, FDMT.

Valuation

Price and trading

Previous close
8.94
Open
8.85
Day range
8.07 – 9.65
52-week range
6.87 – 15.50
Beta
—
Volume
376.12K

Dividends and events

Additional statistics

Market Cap
509.85M
Forward Pe
-4.24
Eps
-35.94
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
15.50
Week52 Low
6.87
Avg Volume
559.28K
Shares Outstanding
62.87M
Ma50
9.44
Ma200
9.44
Pct From52w High
-47.68%
Pct From52w Low
18.05%

Related